[Fully implantable catheter systems. Long-term results--complications]

Area of Science:

• Oncology
• Medical Devices
• Vascular Access

Context:

• Malignant diseases often require long-term parenteral drug administration.
• Totally implantable venous access systems offer a solution for continuous treatment delivery.
• Evaluating the efficacy and safety of these devices in cancer patients is crucial.

Purpose:

• To assess the functionality and complication rates of two types of totally implantable venous access systems.
• To determine the suitability of these devices for long-term parenteral therapy in oncology.
• To analyze patient outcomes and device performance over a defined follow-up period.

Summary:

• 82 patients with malignant diseases received either Port A Cath or Theraport systems.
• The devices functioned normally in 91.5% of patients, with a mean follow-up of 7.2 months.
• Complications included thrombosis, pneumothorax, and infections, occurring in 8.5% of cases.

Impact:

• Totally implantable venous access systems are a valuable supportive measure for patients undergoing long-term chemotherapy.
• These devices improve the quality of life and treatment adherence for cancer patients.
• The study supports the routine use of these systems in managing malignant diseases.